| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $41.7M | +12.0% |
| SG&A Expense | $12.3M | -9.2% |
| Operating Income | -$54.0M | -6.4% |
| Income Tax | $0 | — |
| Net Income | -$34.0M | -31.7% |
| EPS (Basic) | -$0.86 | +0.0% |
| EPS (Diluted) | -$0.86 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.0M | -16.4% |
| Current Assets | $29.6M | -13.6% |
| Total Assets | $30.2M | -14.0% |
| Current Liabilities | $11.1M | +9.6% |
| Total Liabilities | $11.5M | +7.4% |
| Stockholders' Equity | $18.8M | -23.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.5M | -77.8% |
| Capital Expenditures | $4K | -97.3% |
| Investing Cash Flow | -$4K | +97.3% |
| Financing Cash Flow | $23.6M | +421.2% |
| Free Cash Flow | -$28.5M | -76.2% |